Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A retrospective review of 314 cases of contrast-enhanced magnetic resonance imaging (MRI) of the posterior fossa and internal auditory canals was carried out correlating the presenting symptoms with the scan findings. 7.2% of the cases showed findings on the MRI which could account for the patients' symptoms. Patients with
sensorineural hearing loss
were more likely to have a positive scan than those presenting with vertigo and/or tinnitus without hearing loss. Acoustic schwannoma was the most common lesion detected. Labyrinthine lesions e.g. cochlear schwannoma, labyrinthitis, congenital labyrinthine abnormality, and central lesions e.g. multiple sclerosis, brainstem
glioma
were some of the other lesions detected.
...
PMID:Contrast-enhanced magnetic resonance imaging of the internal auditory canals and posterior fossa. 966 3
We report two cases of sixteen year old female patients with NF1 and hearing loss. One patient had only cafe-au-lait spots, while the other patient had severe manifestations of NF1 in form of kyphoscoliosis, requiring multiple laminectomies, vertiginous attacks and optic radiation
glioma
seen on MRI. Other investigations included pure tone audiograms, autoimmune inner ear disease (AIED) tests. The patient with slight manifestations of NFI had mild to moderate low frequency bilateral
sensorineural hearing loss
, which showed 20 dB improvement in hearing threshold with steroid treatment. On the other hand, the patient with severe manifestations of NFI disease had profound
sensorineural hearing loss
with vertiginous episodes. Hearing loss which is usually seen in patients with acoustic neuroma, neurofibromatosis type II, is also an important symptom in patients with neurofibromatosis type I.
...
PMID:Hearing loss in neurofibromatosis type 1: report of two cases. 1044 37